The people
What they build
Open roles via the TechTO Job Board
Working at Strainprint
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. Strainprint’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
On the TechTO stage
Every talk is searchable — ask the archive about Strainprint ↗
About
Strainprint, founded in Toronto in 2016 by Stephanie Karasick, set out to fill the evidence gap in medical cannabis. Patients track sessions in a mobile journaling app, and the anonymized data feeds analytics that help clinicians, formulators and licensed producers understand how products affect people. President and CTO David Berg described the immature, cyclical cannabis market on the TechTO stage in early 2020. The company remains active in 2026, running the app, analytics products and a North American ambassador program.
Backers
Raised a US$3M (CAD$3.8M) Series A in 2018 per a company press release; the round's investors were not named in sources found, and current ownership and funding status are not confirmed.
Quick answers
What does Strainprint do?
It runs a mobile app where medical-cannabis patients journal their sessions and symptoms, then turns that anonymized data into analytics and reports for researchers, clinicians and licensed producers.
Is Strainprint still operating?
Yes. As of 2026 the app is live on the iOS and Android stores, the company sells analytics and reports, and it launched a North American ambassador program in January 2026.
Who founded Strainprint?
Stephanie Karasick, who became a cannabis patient and built the company to advance the scientific understanding of cannabis. David Berg, who spoke at TechTO, is its president and CTO, not a founder.